Treatment of Severe Atopic Dermatitis With Upadacitinib in Clinical Practice: Short-Term Efficacy and Safety Results

被引:11
|
作者
Pereyra-Rodriguez, J. J. [1 ,17 ]
Herranz, P. [2 ]
Figueras-Nart, I [3 ]
Perez, B. [4 ]
Elosua, M. [5 ]
Munera-Campos, M. [6 ]
Melgosa-Ramos, J. [7 ]
Zaragoza, V [8 ]
Silvestre, J. F. [9 ]
Campos-Dominguez, M. [10 ]
Guilabert, A. [11 ]
Miquel, J. [12 ]
Alcantara-Luna, S. [13 ]
de la Cueva, P. [14 ]
Serra-Baldrich, E. [15 ]
Armario-Hita, J. C. [16 ]
Rodriguez, Jose Juan Pereyra
机构
[1] Univ Hosp Virgen Rocio, Dept Dermatol, Seville, Spain
[2] Univ Hosp La Paz, Dept Dermatol, Madrid, Spain
[3] Univ Hosp Bellvitge, Dept Dermatol, Barcelona, Spain
[4] Univ Hosp Ramon & Cajal, Dept Dermatol, Madrid, Spain
[5] Univ Hosp Puerta Hierro, Dept Dermatol, Madrid, Spain
[6] Univ Hosp Germans Trias i Pujol, Dept Dermatol, Badalona, Spain
[7] Univ Hosp Doctor Peset, Dept Dermatol, Valencia, Spain
[8] Univ Hosp Gen Valencia, Dept Dermatol, Valencia, Spain
[9] Univ Hosp Alicante, Dept Dermatol, Alicante, Spain
[10] Univ Hosp Gregorio Maranon, Dept Dermatol, Madrid, Spain
[11] Gen Hosp Granollers, Dept Dermatol, Barcelona, Spain
[12] Univ Hosp Arnau Vilanova, Dept Dermatol, Valencia, Spain
[13] Juan Ramon Jimenez Hosp, Dept Dermatol, Huelva, Spain
[14] Infanta Leonor Hosp, Dept Dermatol, Madrid, Spain
[15] St Pau Hosp, Dept Dermatol, Barcelona, Spain
[16] Univ Hosp Puerto Real, Dept Dermatol, Puerto Real, Spain
[17] Univ Hosp Virgen del Roci, Dept Dermatol, Avda Manuel Siurot S-N, Seville 41013, Spain
关键词
Atopic dermatitis; Atopic eczema; Upadacitinib; JAK-inhibitors; Real-world evidence; DOUBLE-BLIND; ADOLESCENTS; PLACEBO; ADULTS;
D O I
10.18176/jiaci.0831
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:211 / 213
页数:3
相关论文
共 50 条
  • [31] Efficacy and safety of long-term treatment with cyclosporin A for atopic dermatitis
    Hijnen, D. J.
    Berge, O. ten
    Timmer-de Mik, L.
    Bruijnzeel-Koomen, C. A. F. M.
    de Bruin-Weller, M. S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (01) : 85 - 89
  • [32] Efficacy and safety of switching from dupilumab to upadacitinib in moderate-to-severe atopic dermatitis: results from an open-label extension trial
    Blauvelt, A.
    Ladizinski, B.
    Prajapati, V. H.
    Laquer, V.
    Fischer, A.
    Eisman, S.
    Wu, T.
    Vigna, N.
    Teixeira, H. D.
    Liu, J.
    Eyerich, K.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E142 - E142
  • [33] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [34] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [35] The Clinical Efficacy, Safety and Functionality of Anion Textile in the Treatment of Atopic Dermatitis
    Kim, Sang Hyun
    Hwang, Sung Hwan
    Hong, Soon Kwon
    Seo, Jong Keun
    Sung, Ho Suk
    Park, Sung Wook
    Shin, Jeong Hwan
    ANNALS OF DERMATOLOGY, 2012, 24 (04) : 438 - 443
  • [36] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
  • [37] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, S.
    Brunner, P. M.
    Garcet, S.
    Finney, R.
    Cohen, S. R.
    Oliva, M.
    Dutt, R.
    Fuentes-Duculan, J.
    Zheng, X.
    Li, X.
    Bonifacio, K. M.
    Kunjravia, N.
    Coats, I.
    Cueto, I.
    Gilleaudeau, P.
    Sullivan-Whalen, M.
    Suarez-Farinas, M.
    Krueger, J. G.
    Guttman-Yassky, E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2016, 136 (05) : S41 - S41
  • [38] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Xu, Xinghua
    Zheng, Yi
    Zhang, Xin
    He, Yanling
    Li, Chengxin
    ONCOTARGET, 2017, 8 (65) : 108480 - 108491
  • [39] Efficacy and safety of 611 for the treatment of moderate-to-severe atopic dermatitis in adults
    Zhang, Jianzhong
    Zhao, Yan
    Zhou, Qinghong
    Xu, Yuyu
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : I54 - I55
  • [40] Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study
    Jo, Christine E.
    Georgakopoulos, Jorge R.
    Ladda, Matthew
    Ighani, Arvin
    Mufti, Asfandyar
    Drucker, Aaron M.
    Piguet, Vincent
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1530 - 1532